Parion Sciences
Phase 2Parion Sciences is a development stage company dedicated to research, development, and commercialization of therapies to restore the innate mucosal surface defense of the lung.
Founded
2000
Focus
Small Molecules
About
Parion Sciences is a development stage company dedicated to research, development, and commercialization of therapies to restore the innate mucosal surface defense of the lung.
Funding History
2Total raised: $102M
Series B$72MNovo HoldingsSep 15, 2015
Series A$30MNovo HoldingsMay 15, 2010
Company Info
TypePrivate
Founded2000
LocationDurham, United States
StagePhase 2
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile